The effect of ATM and ERK1/2 inhibition on mitoxantrone-induced cell death of leukaemic cells

Folia Biologica (Czech Republic)

Volumn 57, Issue 2, 2011, Pages 74-81

  Seifrtova M ^a   Havelek, R ^a   Chmelarova M ^a   Cmielova J ^a   Muthna D ^a   Stoklasova A ^a   Zemankova S ^a   Rezacova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ATM; ERK1 2; Leukaemia; Mitoxantrone; P53

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ATM PROTEIN; CHECKPOINT KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOXANTRONE; PROTEIN P21; PROTEIN P53; SERINE; 1,3 BUTADIENE DERIVATIVE; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; NITRILE; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN PHOSPHORYLATION; UPREGULATION; APOPTOSIS; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LEUKEMIA CELL LINE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTADIENES; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; G2 PHASE; HUMANS; JURKAT CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOXANTRONE; NITRILES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 82255170926     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., Stark, G. R. (1998) The p53 network. J. Biol. Chem. 273, 1-4. (Pubitemid 28042164)
2. Buschmann, T., Adler, V., Matusevich, E., Fuchs, S. Y., Ronai, Z. (2000) p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p3000/CBP during cell cycle and after exposure to ultraviolet irradiation. Cancer Res. 60, 896-900. (Pubitemid 30129523)
3. Derheimer, F. A., Kastan, M. B. (2010) Multiple roles of ATM in monitoring and maintainig DNA integrity. FEBS Lett. 584, 3675-3681.
4. Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., Valerie, K. (2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res. 67, 1046-53.
5. Harris, C. C. (1996) p53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis 17, 1187-1198. (Pubitemid 26196329)
6. Khanna, K. K., Lavin, M. F., Jackson, S. P., Mulhern, T. D., (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 11, 1052-1065. (Pubitemid 33061823)
7. Malmlöf, M., Roudier, E., Högberg. J., Stenius, U. (2007) MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated in response to inhibited Akt signaling. J. Biol. Chem. 282, 2288-2296. (Pubitemid 47076785)
8. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., Elledge, S. J. (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97, 10389-10394.
9. Phelps, M., Phillips, A., Darley, M., Blaydes, J. P. (2005) MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm. J. Biol. Chem. 280, 16651-16658. (Pubitemid 41389122)
10. Qi, M., Elion, E. A. (2005) MAP kinase pathways. J. Cell Sci. 118, 3569-3572. (Pubitemid 41309404)
11. Roux, P. P., Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344. (Pubitemid 38756868)
12. Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., Xie, D. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-10124. (Pubitemid 27357721)
13. Shieh, S. Y., Ikeda, M., Taya, Y., Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334. (Pubitemid 27467963)
14. Szkanderová, S., Vávrová, J., Řezá čová, M., Vokurková, D., Pavlová, S., Smardová, J., Stulik, J. (2003) Gamma irradiation results in phosphorylation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Folia Biol. (Praha) 49, 191-196. (Pubitemid 37508701)
15. Thompson, T., Tovar, C., Yang, H., Carvajal, D., Vu, B. T., Xu, Q., Wahl, G. M., Heimbrook, D. C., Vassilev, L. T. (2004) Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem. 279, 53015-53022. (Pubitemid 40051800)
16. Toledo, F., Wahl, G. M. (2007) MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. 39, 1467-1482.
17. Vávrová, M., Mareková- Řezáčová, M., Vokurková, D., Szkanderová, S., Psutka, J. (2003) Caffeine induces a second wave of apoptosis after low dose-rate γ radiation of HL-60 cells. Radiat. Environ. Biophys. 42, 193-199. (Pubitemid 37518064)
18. Yan, Y., Black, C.P., Cowan, K.H. (2007) Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 26, 4689-4698. (Pubitemid 47067411)